Volume 22, Number 1—January 2016
Dispatch
Variations in Spike Glycoprotein Gene of MERS-CoV, South Korea, 2015
Table 1
Patient | Sequence | Date of symptom onset/sample collection | Sample | Sequencing method | GenBank accession no. |
---|---|---|---|---|---|
PAT001 | CoV/KOR/KNIH/001_05_2015 | 11/19 | Sputum | Illumina,† Sanger | KT182958 |
PAT002 | CoV/KOR/KNIH/002_05_2015 | 19/20 | Third-passage isolate from Vero cells | Illumina | KT029139 |
PAT009 | CoV/KOR/KNIH/009_05_2015 | 27/28 | Sputum | Illumina | KT182953 |
PAT010 | ChinaGD01‡ | 19/27 | Nasopharyngeal swab | Ion torrent,§ Sanger | KT006149 |
PAT012 | CoV/KOR/KNIH/012_05_2015 | 21/28 | Sputum | Sanger | KT182954 |
PAT013 | CoV/KOR/KNIH/013_05_2015 | 21/28 | Sputum | Sanger | KT182955 |
PAT015 | CoV/KOR/KNIH/015_05_2015 | 22/30 | Sputum | Illumina | KT182956 |
PAT042 | CoV/KOR/KNIH/042_05_2015 | 25/30 | Sputum | Illumina | KT182957 |
*MERS-CoV, Middle East respiratory syndrome coronavirus.
†Illumina (San Diego, CA, USA).
‡Sequence obtained from the Chinese Centers for Disease Control and Prevention (Beijing, China).
§Life Technologies (Bleiswijk, the Netherlands).
1These authors contributed equally to this article.
Page created: December 18, 2015
Page updated: December 18, 2015
Page reviewed: December 18, 2015
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.